Psychometric properties of the 8-item Morisky Medication Adherence Scale in patients taking warfarin

Ye Wang, Ming Chai Kong, Yu Ko

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

There is no patient-reported medication adherence measure that has been validated in Singapore. This study aimed to validate the 8-item Morisky Medication Adherence Scale (MMAS) in patients taking warfarin in Singapore. A cross-sectional survey was conducted in a convenience sample of 151 patients taking warfarin at an anticoagulation clinic in 2011. Respondents completed the MMAS in English or Chinese depending on their preference. The MMAS had a Cronbach's alpha of 0.56 and good criterion-related validity as the scale scores were associated with warfarin refill rates (p = 0.04). Respondents with higher MMAS scores were found to have a higher percentage of International Normalised Ratios (INRs) within the therapeutic range (p = 0.01), higher adherence to diet recommendations (p = 0.02), and less perceived difficulty in taking all medications (p <0.001); they were also more likely to take warfarin at the same time every day (p <0.001). Confirmatory factor analysis showed that the eight items loaded onto one factor (RMSEA = 0.03). The sensitivity, specificity, positive predictive value and negative predictive value of the MMAS for identifying patients with poor INR control were 73.0%, 35.6%, 49.5% and 60.5%, respectively, using the time in the therapeutic INR range as the gold standard. This study shows that the 8-item MMAS has good validity and moderate reliability in patients taking warfarin. Future research is needed to investigate the scale's psychometric properties in other patient populations and clinical settings.

Original languageEnglish
Pages (from-to)789-795
Number of pages7
JournalThrombosis and Haemostasis
Volume108
Issue number4
DOIs
Publication statusPublished - Sep 2012
Externally publishedYes

Fingerprint

Medication Adherence
Warfarin
Psychometrics
International Normalized Ratio
Singapore
Reproducibility of Results
Statistical Factor Analysis
Cross-Sectional Studies
Diet
Sensitivity and Specificity
Therapeutics
Population

Keywords

  • Anticoagulation
  • Medication adherence
  • Morisky medication adherence scale
  • Warfarin

ASJC Scopus subject areas

  • Hematology

Cite this

Psychometric properties of the 8-item Morisky Medication Adherence Scale in patients taking warfarin. / Wang, Ye; Kong, Ming Chai; Ko, Yu.

In: Thrombosis and Haemostasis, Vol. 108, No. 4, 09.2012, p. 789-795.

Research output: Contribution to journalArticle

@article{c2281b216c1e4d858e237a3396a0eb4e,
title = "Psychometric properties of the 8-item Morisky Medication Adherence Scale in patients taking warfarin",
abstract = "There is no patient-reported medication adherence measure that has been validated in Singapore. This study aimed to validate the 8-item Morisky Medication Adherence Scale (MMAS) in patients taking warfarin in Singapore. A cross-sectional survey was conducted in a convenience sample of 151 patients taking warfarin at an anticoagulation clinic in 2011. Respondents completed the MMAS in English or Chinese depending on their preference. The MMAS had a Cronbach's alpha of 0.56 and good criterion-related validity as the scale scores were associated with warfarin refill rates (p = 0.04). Respondents with higher MMAS scores were found to have a higher percentage of International Normalised Ratios (INRs) within the therapeutic range (p = 0.01), higher adherence to diet recommendations (p = 0.02), and less perceived difficulty in taking all medications (p <0.001); they were also more likely to take warfarin at the same time every day (p <0.001). Confirmatory factor analysis showed that the eight items loaded onto one factor (RMSEA = 0.03). The sensitivity, specificity, positive predictive value and negative predictive value of the MMAS for identifying patients with poor INR control were 73.0{\%}, 35.6{\%}, 49.5{\%} and 60.5{\%}, respectively, using the time in the therapeutic INR range as the gold standard. This study shows that the 8-item MMAS has good validity and moderate reliability in patients taking warfarin. Future research is needed to investigate the scale's psychometric properties in other patient populations and clinical settings.",
keywords = "Anticoagulation, Medication adherence, Morisky medication adherence scale, Warfarin",
author = "Ye Wang and Kong, {Ming Chai} and Yu Ko",
year = "2012",
month = "9",
doi = "10.1160/TH12-05-0368",
language = "English",
volume = "108",
pages = "789--795",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "4",

}

TY - JOUR

T1 - Psychometric properties of the 8-item Morisky Medication Adherence Scale in patients taking warfarin

AU - Wang, Ye

AU - Kong, Ming Chai

AU - Ko, Yu

PY - 2012/9

Y1 - 2012/9

N2 - There is no patient-reported medication adherence measure that has been validated in Singapore. This study aimed to validate the 8-item Morisky Medication Adherence Scale (MMAS) in patients taking warfarin in Singapore. A cross-sectional survey was conducted in a convenience sample of 151 patients taking warfarin at an anticoagulation clinic in 2011. Respondents completed the MMAS in English or Chinese depending on their preference. The MMAS had a Cronbach's alpha of 0.56 and good criterion-related validity as the scale scores were associated with warfarin refill rates (p = 0.04). Respondents with higher MMAS scores were found to have a higher percentage of International Normalised Ratios (INRs) within the therapeutic range (p = 0.01), higher adherence to diet recommendations (p = 0.02), and less perceived difficulty in taking all medications (p <0.001); they were also more likely to take warfarin at the same time every day (p <0.001). Confirmatory factor analysis showed that the eight items loaded onto one factor (RMSEA = 0.03). The sensitivity, specificity, positive predictive value and negative predictive value of the MMAS for identifying patients with poor INR control were 73.0%, 35.6%, 49.5% and 60.5%, respectively, using the time in the therapeutic INR range as the gold standard. This study shows that the 8-item MMAS has good validity and moderate reliability in patients taking warfarin. Future research is needed to investigate the scale's psychometric properties in other patient populations and clinical settings.

AB - There is no patient-reported medication adherence measure that has been validated in Singapore. This study aimed to validate the 8-item Morisky Medication Adherence Scale (MMAS) in patients taking warfarin in Singapore. A cross-sectional survey was conducted in a convenience sample of 151 patients taking warfarin at an anticoagulation clinic in 2011. Respondents completed the MMAS in English or Chinese depending on their preference. The MMAS had a Cronbach's alpha of 0.56 and good criterion-related validity as the scale scores were associated with warfarin refill rates (p = 0.04). Respondents with higher MMAS scores were found to have a higher percentage of International Normalised Ratios (INRs) within the therapeutic range (p = 0.01), higher adherence to diet recommendations (p = 0.02), and less perceived difficulty in taking all medications (p <0.001); they were also more likely to take warfarin at the same time every day (p <0.001). Confirmatory factor analysis showed that the eight items loaded onto one factor (RMSEA = 0.03). The sensitivity, specificity, positive predictive value and negative predictive value of the MMAS for identifying patients with poor INR control were 73.0%, 35.6%, 49.5% and 60.5%, respectively, using the time in the therapeutic INR range as the gold standard. This study shows that the 8-item MMAS has good validity and moderate reliability in patients taking warfarin. Future research is needed to investigate the scale's psychometric properties in other patient populations and clinical settings.

KW - Anticoagulation

KW - Medication adherence

KW - Morisky medication adherence scale

KW - Warfarin

UR - http://www.scopus.com/inward/record.url?scp=84867256254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867256254&partnerID=8YFLogxK

U2 - 10.1160/TH12-05-0368

DO - 10.1160/TH12-05-0368

M3 - Article

VL - 108

SP - 789

EP - 795

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 4

ER -